Charles Schwab’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-860,764
Closed -$69M 3107
2016
Q4
$69M Buy
860,764
+26,869
+3% +$2.13M 0.08% 256
2016
Q3
$66.5M Buy
833,895
+17,476
+2% +$1.41M 0.08% 256
2016
Q2
$63.7M Sell
816,419
-161,460
-17% -$11.5M 0.08% 255
2016
Q1
$53.8M Buy
977,879
+74,948
+8% +$4.08M 0.07% 283
2015
Q4
$55.8M Buy
902,931
+79,870
+10% +$5.04M 0.08% 264
2015
Q3
$51.9M Buy
823,061
+7,886
+1% +$563K 0.08% 256
2015
Q2
$59.6M Buy
815,175
+12,128
+2% +$876K 0.08% 238
2015
Q1
$52.5M Buy
803,047
+19,830
+3% +$1.32M 0.07% 264
2014
Q4
$50.9M Buy
783,217
+21,165
+3% +$1.36M 0.08% 254
2014
Q3
$45.8M Sell
762,052
-100
-0% -$6.53K 0.08% 248
2014
Q2
$52.8M Buy
762,152
+33,168
+5% +$2.15M 0.09% 220
2014
Q1
$47.7M Buy
728,984
+40,237
+6% +$2.62M 0.09% 228
2013
Q4
$42.7M Buy
688,747
+94,479
+16% +$5.47M 0.08% 233
2013
Q3
$32.4M Buy
594,268
+9,635
+2% +$496K 0.07% 283
2013
Q2
$26.8M Buy
+584,633
New +$25.3M 0.06% 306

Other funds holding STJ

Charles Schwab's STJ Position: Q1 2017 in Review

Charles Schwab sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 860,764 shares — an estimated $69M sold.

Charles Schwab first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $69M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Charles Schwab reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Charles Schwab sold 860,764 St Jude Medical shares in Q1 2017, an estimated $69M.
  • Charles Schwab first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Charles Schwab's St Jude Medical position peaked at $69M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.